BGS
B&G Foods, Inc.
BGS trails on the overall score without a compensating advantage in the available component scores.
CELH
Celsius Holdings, Inc.
CELH has the edge over BGS overall, supported by stronger fundamentals and stronger valuation.
BGS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
BGS's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BGS PE Valuation
BGS has no meaningful PE right now: it lost money over the past year.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
BGS Forward outlook
There aren't enough analyst estimates for BGS to show an outlook.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
BGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.05 | +$2.11 |
| Q2 2026 | -$0.89 | +$1.94 |
| Q1 2026 | -$0.96 | +$1.70 |
| Q4 2025 | -$0.54 | +$2.64 |
| Q3 2025 | -$3.16 | -$2.81 |
| Q2 2025 | -$2.83 | -$1.28 |
| Q1 2025 | -$2.66 | -$1.21 |
| Q4 2024 | -$3.18 | -$2.29 |
BGS is still losing money, but far less than before: $1.05 per share over the past year, against $3.18 at its worst in late 2024.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over BGS on earnings quality, reporting a profit while its opponent remains loss making.
BGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $459.8M | +4.7% |
| Q2 2026 | $383.3M | -9.7% |
| Q1 2026 | $408.9M | -3.9% |
| Q4 2025 | $539.6M | -2.2% |
| Q3 2025 | $439.3M | -4.7% |
| Q2 2025 | $424.4M | -4.5% |
| Q1 2025 | $425.4M | -10% |
| Q4 2024 | $551.6M | -4.6% |
BGS's revenue fell from its 2022 peak and has held roughly level since: $460M last quarter, up 4.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.1% | +0.6 points |
| Q2 2026 | 9% | +3.8 points |
| Q1 2026 | -2.7% | -11 points |
| Q4 2025 | 5.2% | +52 points |
| Q3 2025 | 2.5% | -8.6 points |
| Q2 2025 | 5.2% | -4.7 points |
| Q1 2025 | 8.4% | +12 points |
| Q4 2024 | -47% | -54 points |
BGS's operating margin was 3.1% last quarter, up 0.6 points from the same quarter a year ago.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over BGS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over BGS on profitability, with a higher operating margin.
BGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$35.2M | +$35.6M |
| Q2 2026 | $28.2M | +147% |
| Q1 2026 | $18.7M | -56% |
| Q4 2025 | $87.7M | +22% |
| Q3 2025 | -$70.7M | -$70M |
| Q2 2025 | $11.5M | +122% |
| Q1 2025 | $42.4M | +54% |
| Q4 2024 | $71.7M | -14% |
BGS has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
BGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +21.5K shares |
| 1 year | +1.5% | +1.2M shares |
| 3 years | +9.1% | +6.8M shares |
| 5 years | +24% | +15.7M shares |
| Available history | +25% | +16.2M shares |
BGS has 81M diluted shares, up 1.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over BGS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
BGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 15.7x | High |
| Q2 2026 | 15.4x | High |
| Q1 2026 | 16.9x | High |
| Q4 2025 | 11.6x | High |
| Q3 2024 | 10.7x | High |
| Q2 2024 | 30.3x | High |
| Q1 2024 | 27.9x | High |
| Q4 2023 | 13.4x | High |
BGS's net debt is about 16 years of its operating earnings (EBITDA), up from 11 years a year ago.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over BGS on leverage, with a lower net debt burden relative to earnings.
BGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.2 | Neutral |
| Stochastic | 39.9 | Neutral |
BGS's weekly RSI is 50 (neutral) and its Stochastic is 40 (neutral).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BGS PE vs Consumer Defensive Sector
| Metric | BGS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
BGS has no meaningful PE right now: it lost money over the past year.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
BGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.59 | 29% above |
| 20 week MA | $3.15 | 6.3% above |
| 50 week MA | $4.10 | 18% below |
| 100 week MA | $4.71 | 29% below |
| 200 week MA | $7.75 | 57% below |
BGS has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 57% below its 200-week average.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
BGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.2 | $30.5 | +67% |
| 2021 | $30.5 | $31.2 | +2.4% |
| 2022 | $31.2 | $11.7 | -63% |
| 2023 | $11.7 | $10.5 | -9.9% |
| 2024 | $10.5 | $7.09 | -32% |
| 2025 | $7.09 | $4.57 | -36% |
| 2026 YTD | $4.57 | $3.35 | -27% |
BGS has the edge over CELH on returns for 2026, with the stronger performance.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.